REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $66,000 | +94.1% | 2,453 | 0.0% | 0.01% | +100.0% |
| Q2 2022 | $34,000 | -15.0% | 2,453 | +20.8% | 0.01% | 0.0% |
| Q1 2022 | $40,000 | +37.9% | 2,031 | +15.3% | 0.01% | +25.0% |
| Q4 2021 | $29,000 | -48.2% | 1,762 | -13.5% | 0.00% | -42.9% |
| Q3 2021 | $56,000 | -5.1% | 2,036 | +0.8% | 0.01% | -12.5% |
| Q2 2021 | $59,000 | +9.3% | 2,019 | +4.1% | 0.01% | 0.0% |
| Q1 2021 | $54,000 | -14.3% | 1,940 | -12.8% | 0.01% | -20.0% |
| Q4 2020 | $63,000 | – | 2,224 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |